Clinical Trial Update: Phase 2a Study of IW-6463 in Adults Diagnosed With Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes (MELAS) [Phase 2]

View source ↗

Summary

A Phase 2a trial of IW-6463 in adults with MELAS was terminated, and results were posted in November 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mitochondrial Encephalomyopathy Lactic Acidosis and Stroke-like Episodes

Drugs mentioned

• IW-6463 (IW-6463)

Snippet

Sponsor: Tisento Therapeutics | Conditions: MELAS | Phase 2 | Status: TERMINATED | Results posted: 2023-11-15